Australia markets closed

Inovio Pharmaceuticals, Inc. (INO.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
172.00-3.00 (-1.71%)
At close: 10:00AM CST
Currency in MXN

Valuation measures4

Market cap (intra-day) 4.47B
Enterprise value 2.52B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)269.97
Price/book (mrq)2.24
Enterprise value/revenue 3.02k
Enterprise value/EBITDA -19.29

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 34.17%
S&P500 52-week change 322.64%
52-week high 3235.00
52-week low 375.00
50-day moving average 3174.31
200-day moving average 3117.83

Share statistics

Avg vol (3-month) 31.31k
Avg vol (10-day) 3357
Shares outstanding 525.91M
Implied shares outstanding 626.78M
Float 823.03M
% held by insiders 11.48%
% held by institutions 116.66%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 325 Jan 2024

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-26,686.29%

Management effectiveness

Return on assets (ttm)-32.11%
Return on equity (ttm)-79.55%

Income statement

Revenue (ttm)832.01k
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)-17.70%
Gross profit (ttm)N/A
EBITDA -130.66M
Net income avi to common (ttm)-135.12M
Diluted EPS (ttm)-103.41
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)145.29M
Total cash per share (mrq)6.22
Total debt (mrq)30.21M
Total debt/equity (mrq)25.74%
Current ratio (mrq)3.60
Book value per share (mrq)5.15

Cash flow statement

Operating cash flow (ttm)-124.37M
Levered free cash flow (ttm)-86.15M